As even more evidenced by this settlement, the DOJ and SEC go on to sign the risks related to ill-defined pools of reimbursable distributor fees (e.g. “advertising and marketing” or “administration” expenses), using no cost samples, rebates, and various rate concessions. The Alcon and Novartis AG DPAs certainly are a reminder of the value o